Ventricular tachycardia syndromes.
Better understanding of the underlying mechanism and substrate of different VTs has made it possible to tailor treatment strategies properly. The advent of sophisticated device-based therapy and of more precise and effective catheter ablation approaches will expand clinicians' ability to gain control of this multifaceted arrhythmia syndrome.
Saliba
W I
WI
Department of Cardiology, Section of Pacing and Electrophysiology, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Natale
A
A
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000150:complications; D017115:Catheter Ablation; D003327:Coronary Disease / Q000150:complications; D003937:Diagnosis, Differential; D006801:Humans; D015994:Incidence; D011379:Prognosis; D012307:Risk Factors; D015996:Survival Rate; D013577:Syndrome; D017180:Tachycardia, Ventricular / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D014481:United States / Q000453:epidemiology
D000889:Anti-Arrhythmia Agents